This Article Abstract Full Text (PDF) Methods Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lynn, S. Articles by Jan, K.-Y. Search for Related Content PubMed PubMed Citation Articles by Lynn, S. Articles by Jan, K.-Y. Related Collections Smooth muscle proliferation and differentiation Peripheral vascular disease Oxidant stress Mechanism of atherosclerosis/growth factors

(Circulation Research. 2000;86:514.)
© 2000 American Heart Association, Inc.

Molecular Medicine

NADH Oxidase Activation Is Involved in Arsenite-Induced Oxidative DNA Damage in Human Vascular Smooth Muscle Cells

Shugene Lynn, Jia-Ran Gurr, Hsien-Tsung Lai, Kun-Yan Jan

From the Institute of Zoology, Academia Sinica, Taipei, Taiwan, ROC.

Correspondence to K.Y. Jan, Institute of Zoology, Academia Sinica, Taipei 11529, Taiwan, ROC. E-mail zojky{at}sinica.edu.tw

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
Abstract—Arsenic is atherogenic, carcinogenic, and genotoxic. Because atherosclerotic plaque has been considered a benign smooth muscle cell tumor, we have studied the effects of arsenite on DNA integrity of human vascular smooth muscle cells. By using single-cell alkaline electrophoresis, apparent DNA strand breaks were detected in a 4-hour treatment with arsenite at a concentration above 1 µmol/L. DNA strand breaks of arsenite-treated cells were increased by Escherichia coli formamidopyrimidine–DNA glycosylase and decreased by diphenylene iodinium, superoxide dismutase, catalase, pyruvate, DMSO, or D-mannitol. Extract from arsenite-treated cells showed increased capacity for producing superoxide when NADH was included in the reaction mixture; however, addition of arsenite to extract from untreated cells did not increase superoxide production. The superoxide-producing ability of arsenite-treated cells was also suppressed by diphenylene iodinium, 4,5-dihydroxy-1,2-benzenedisulfonic acid disodium salt (Tiron), or superoxide dismutase. Superoxide production and DNA strand breaks in arsenite-treated cells were also suppressed by transfecting antisense oligonucleotides of p22phox, an essential component of NADH oxidase. Treatment with arsenite also increased the mRNA level of p22phox. These results suggest that arsenite activates NADH oxidase to produce superoxide, which then causes oxidative DNA damage. The result that arsenite at low concentrations increases oxidant levels and causes oxidative DNA damage in vascular smooth muscle cells may be important in arsenic-induced atherosclerosis.

Key Words: arsenite • oxidative DNA damage • NADH oxidase • atherosclerosis

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
Arsenic, an element present in the earth’s crust, comes to the surface through mining and utilization of groundwater. Serious contamination by inorganic arsenic occurs through long-term ingestion of high concentrations of arsenic in drinking water. Chronic exposure to arsenic has been related to increased incidences of skin, lung, bladder, liver, and kidney cancers.^{1 2} Arsenic exposure is also associated with various vascular disorders, including angiosarcomas,³ atherosclerotic plaques,⁴ and hypertension in humans.⁵

The epidemiological evidence for shared risk factors for cancer and atherosclerosis has been reviewed by Hansen.⁶ Exposure to carcinogenic environmental agents is associated with an increased risk of atherosclerosis. Therefore, somatic mutation and cell proliferation may play a role in the pathogenesis of atherosclerotic plaques. The predominant cell type in plaques is the vascular smooth muscle cell (VSMC). Proliferation of VSMCs is essential for plaque formation and development. By examining the isoenzymes of glucose-6-phosphate dehydrogenase, human atherosclerotic plaques were shown to be monoclonal in origin.⁷ Furthermore, DNA samples from human coronary artery plaques were demonstrated to transform NIH3T3 cells.⁸ These observations suggest that atherosclerotic plaques are presumably benign smooth muscle cell tumors and that somatic mutation of VSMCs may play a role in the pathogenesis of atherosclerotic plaque.

In humans, exposure to arsenic has been shown to be associated with increased frequency of chromosomal aberrations⁹ and sister chromatid exchange.¹⁰ Arsenite has also been shown to induce gene mutation in human fibroblasts.¹¹ Therefore, genotoxic effects may be the common etiology in arsenic-induced carcinogenesis and atherogenesis. Although arsenite (20 to 80 µmol/L)¹² and methylated arsenic (at mmol/L level)¹³ have been reported to induce DNA strand breaks in cultured mammalian cells, the involvement of arsenic-induced DNA damage in human disorders is somewhat unconvincing, because the concentrations of arsenic used were beyond the range of normal exposure. In Blackfoot disease–affected areas of Taiwan, arsenic concentrations in drinking water and in red blood cells of residents¹⁴ can reach 15 and 1.2 µmol/L, respectively. Therefore, we examined the effect of arsenite at 1 to 10 µmol/L levels on DNA integrity of human VSMCs. The results show that arsenite at this concentration range can increase NADH oxidase activity and induce DNA strand breaks.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Cell Culture
Human aorta VSMCs (American Type Culture Collection, CRL-1999) were grown in F12K medium with 2 mmol/L L-glutamine; 1.5 g/L sodium bicarbonate; 10% FCS; 10 ng/mL sodium selenite; 100 U/mL penicillin; and (in µg/mL) endothelial cell growth supplement 20, transferrin 10, insulin 10, and streptomycin 100.

DNA Strand Breaks
DNA strand breaks were analyzed by single-cell alkaline electrophoresis (comet assay) as described previously.¹⁵

Determination of Superoxide-Producing Activity in Cell Extract
Cells suspended in 0.2 mL lysis buffer ([in mmol/L] monobasic potassium phosphate [pH 7.0] 20, EGTA 1, and PMSF 0.5, as well as [in µg/mL] aprotinin 10, leupeptin 0.5, and pepstatin 0.7) were sonicated for 3 minutes with a 9-s pulse and 1-s off mode. Superoxide was measured by monitoring the chemiluminescence every 10 s for 5 minutes in 50 mmol/L phosphate buffer (pH 7.0), containing 10 µg cell extract, 1 mmol/L EGTA, 150 mmol/L sucrose, 500 µmol/L lucigenin, and either NADH, NADPH, or xanthine (100 µmol/L each) as the electron donor (final volume, 0.5 mL). Using standard curves generated from xanthine and xanthine oxidase, the chemiluminescence was converted to the amount of superoxide.¹⁶ Each determination was based on 3 to 5 samples.

Transfecting With p22phox Antisense and Sense Oligonucleotides
Cells were transfected with 1 µmol/L oligonucleotides with the aid of SuperFect transfection reagent (Qiagen). The oligonucleotides were antisense or sense of p22phox, the subunit of cytochrome b-558. The sequences¹⁷ were as follows: antisense p22phox, 5'-GATCTGCCCCATGGTGAGGACC-3', and sense p22phox, 5'-GGTCCTCACCATGGGGCAGATC-3'.

Reverse Transcription–Polymerase Chain Reaction (RT-PCR)
RT-PCR was performed by a RNA PCR kit (Perkin Elmer). Briefly, 1 µg RNA was mixed in 1x PCR buffer, 5 mmol/L MgCl₂, 1 mmol/L dNTPs, 1 U/µL RNase inhibitor, 2.5 µmol/L oligo(dT)₁₆, and 2.5 U/µL Moloney murine leukemia virus reverse transcriptase. The RT was performed at 42°C for 15 minutes, followed by denaturation at 95°C for 5 minutes. PCRs were performed in duplicates in a total volume of 50 µL, each containing 10 µL of RT reaction buffer, 2 mmol/L MgCl₂, 1x PCR buffer, 0.025 U/µL AmpliTaq DNA polymerase, and 1.5 µmol/L each of sense and antisense primers. The cycle profile included an initial step at 95°C for 105 s, melting at 95°C for 15 s, annealing and extending at 60°C for 30 s, and holding at 72°C for 7 minutes. Thirty-five cycles of melting, annealing, and extending were performed to amplify p22phox and -actin. The sequence of primers for p22phox were 5'-GAGTGGGCCATGTGGGCCAACG-3' and 5'-GGATGGTG-GCCAGCAGGAAG-3',¹⁷ and those for -actin were 5'-ACTGGGACGACATGGAAAAG-3' and 5'-GAAGGAATAGCCACGCTCAG-3'.¹⁸ The sizes of products for p22phox and -actin were 314 and 386 bp, respectively. PCR amplification of RT reactions without reverse transcriptase revealed no PCR product, thus eliminating the possibility of amplifying contaminated DNA (data not shown).

Statistical Analysis
Results are expressed as mean±SE. Statistical analyses were performed with the Student 2-tailed paired t test and ANOVA when more than 2 treatments were compared. * and ** indicate P<0.05 and P<0.01, respectively.

An expanded Materials and Methods section is available online at http://www.circresaha.org.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Effects of Arsenite Treatment on DNA Integrity
In this investigation, the comet assay was done in an alkaline condition (pH 13.4). Thus, the DNA strand breaks included double and single strand breaks and alkali-labile sites. The results show that enhanced DNA migration, an indication of DNA strand breaks, was clearly detected in arsenite-treated cells. With a 4-hour treatment, the extent of DNA strand breaks increased with arsenite concentration (Figure 1), and apparent DNA strand breaks were observed in cells treated with arsenite above 1 µmol/L. Because nitric oxide^{12 19} and reactive oxygen species²⁰ were shown to be involved in arsenite genotoxicity, the effects of their modulators on arsenite-induced DNA strand breaks were studied. The results show that nitric oxide synthase inhibitors, N-nitro-L-arginine methyl ester and S-methyl-L-thiocitrulline, had no apparent effects (Figure 2A). However, superoxide dismutase, catalase, diphenylene iodinium, DMSO, D-mannitol, and pyruvate effectively reduced arsenite-induced DNA strand breaks (Figure 2B). These results suggest that reactive oxygen species, but not nitric oxide, are involved in arsenite-induced DNA strand breaks. We then used Escherichia coli formamidopyrimidine–DNA glycosylase (Fpg) to determine whether oxidized oligonucleotide was induced in arsenite-treated VSMCs. Fpg is known to catalyze the excision of oxidized bases such as formamidopyrimidine and 8-oxoguanine²¹ ; therefore, it will convert these oxidized bases into DNA strand breaks. Fpg incubation increased the DNA strand breaks in H₂O₂-treated as well as in arsenite-treated cells (Figures 3A and 3B). The results presented in Figure 3C indicate that oxidative DNA damage was induced by a 4-hour treatment with 1 µmol/L arsenite.

View larger version (19K): [in this window] [in a new window]   Figure 1. Effect of treatment with arsenite (As) on DNA integrity of VSMCs. A, Cells were treated with 10 µmol/L arsenite for various lengths of time. B, Cells were treated with various concentrations of arsenite for 4 hours. DNA strand breaks were analyzed by comet assay. Pictures are nuclear images of untreated cells (C) and 4-hour 10 µmol/L arsenite-treated cells (D). Results are from 3 independent experiments. **P<0.01, samples with vs samples without arsenite.

View larger version (28K): [in this window] [in a new window]   Figure 2. Effects of nitric oxide and reactive oxygen species modulators on arsenite (As)–induced DNA strand breaks. A, Cells were untreated (Unt) or treated for 4 hours with 10 µmol/L arsenite plus various concentrations of N-nitro-L-arginine methyl ester (As/NAME) or S-methyl-L-thiocitrulline (As/MTC). B, Cells were untreated (Unt) or treated for 4 hours with 10 µmol/L arsenite or with 10 µmol/L arsenite plus 25 µg/mL superoxide dismutase (As/SOD), 25 µg/mL catalase (As/Cat), 10 µmol/L diphenylene iodinium (As/DPI), 0.5% DMSO, 0.5 mmol/L D-mannitol (As/Man), or 1 mmol/L pyruvate (As/Py). Results are from 3 independent experiments. **P<0.01, samples with vs samples without modulator.

View larger version (24K): [in this window] [in a new window]   Figure 3. Effects of E. coli Fpg on DNA strand breaks in arsenite (As)–treated VSMCs. A, Cells untreated (Unt) or treated with 10 µmol/L arsenite for 4 hours (As 10) were lysed and then incubated with 0.5 U/µL Fpg for various lengths of time before electrophoresis. B, Cells treated with various concentrations of arsenite for 4 hours or with 0.5 mmol/L H2O2 for 1 hour were lysed and then incubated with 0.5 U/µL Fpg for 120 minutes before electrophoresis. H and As represent cells treated with H2O2 or arsenite but without Fpg digestion; H/Fpg and As/Fpg, cells treated with H2O2 or arsenite and with Fpg digestion. C, Cells untreated (Unt) or treated with 1 µmol/L arsenite for 4 hours without (open columns) or with (hatched columns) 0.5 U/µL Fpg digestion. Results are from 3 independent experiments.

Effects of Arsenite on NADH Oxidase Activity
To gain further evidence that oxidative DNA damage was induced by treating VSMCs with arsenite, we determined the superoxide-producing ability in cell extract by the lucigenin-mediated chemiluminescence method. The results show that, in the presence of NADH, the extract from arsenite-treated cells generated stronger chemiluminescence than did extract from untreated cells (Figures 4A and 4B), whereas the increase of chemiluminescence in extract from arsenite-treated cells was less when NADPH was used as substrate, and xanthine was unable to support the increase of chemiluminescence in extract from either untreated or arsenite-treated cells (Figures 4A and 4B). The chemiluminescence in extract from arsenite-treated cells was reduced by superoxide dismutase, 4,5-dihydroxy-1,2-benzenedisulfonic acid disodium salt (Tiron, LaMotte), and diphenylene iodinium, but not by allopurinol or N-nitro-L-arginine methyl ester (Figure 4C). These results suggest that the increase of chemiluminescence in extract from arsenite-treated cells is due to the generation of superoxide, which probably comes from the activation of NADH/NADPH oxidase. The increased superoxide generation was dependent on both arsenite concentration and treatment time (Figures 5A and 5B). However, the addition of arsenite to extract from untreated cells decreased superoxide production (Figure 5A).

View larger version (22K): [in this window] [in a new window]   Figure 4. Superoxide-generating activity in extracts from arsenite-treated cells. Cell extracts (2 µg) from untreated cells (A) or from cells treated with 10 µmol/L arsenite for 4 hours (B) were incubated in 0.5 mL superoxide assay buffer containing NADH, NADPH, or xanthine (100 µmol/L each). Chemiluminescences were measured at various time points. Results of panels A and B are from 1 of 3 experiments giving similar results. C, Effects of oxidant modulators on the superoxide generation of extract from arsenite (As)–treated cells. Extracts (2 µg) from cells treated with 10 µmol/L arsenite for 4 hours were incubated in 0.5 mL superoxide assay buffer containing 100 µmol/L NADH without or with 50 µg/mL superoxide dismutase (As/SOD), 10 mmol/L Tiron (As/Tiron), 100 µmol/L diphenylene iodinium (As/DPI), 100 µmol/L allopurinol (As/Allo), or 100 µmol/L N-nitro-L-arginine methyl ester (As/NAME). Extracts from untreated cells were incubated in superoxide assay buffer containing NADH (Unt). Chemiluminescences were measured after a 5-minute incubation. Results are from 3 independent experiments. **P<0.01, samples with vs samples without modulator.

View larger version (21K): [in this window] [in a new window]   Figure 5. Effects of arsenite on NADH oxidase activity. A, Extracts (6 µg) from cells treated with various concentrations of arsenite for 4 hours (•) were incubated for 5 minutes in superoxide assay buffer containing 100 µmol/L NADH, and extracts from untreated cells were incubated in superoxide assay buffer containing 100 µmol/L NADH and various concentrations of arsenite for 5 minutes (). B, Extracts (6 µg) from cells treated with 10 µmol/L arsenite for various lengths of time were incubated in the superoxide assay buffer containing 100 µmol/L NADH for 5 minutes, and then chemiluminescences were measured. Results are from 3 independent experiments.

Effects of p22phox mRNA Expression on Arsenite-Induced Superoxide and DNA Strand Breaks
The molecular structure of VSMC NADH oxidase, which bears some similarity to NADPH oxidase of neutrophils, is composed of at least 7 subunits. In VSMCs, upregulation of one of the subunits, p22phox, is a pivotal mechanism for NADH oxidase.²² To confirm that NADH oxidase is activated in arsenite-treated cells, we interfered with the expression of NADH oxidase by transfecting a p22phox antisense oligonucleotide. The results indicate that transfection with p22phox antisense oligonucleotide markedly reduced superoxide production and DNA strand breaks in arsenite-treated cells (Figures 6A and 6B), whereas transfection with p22phox sense oligonucleotide slightly reduced arsenite-increased superoxide production (Figure 6A) but did not suppress arsenite-induced DNA strand breaks (Figure 6B). We also studied the effects of arsenite treatment on the expression of p22phox mRNA by RT-PCR. The results show that arsenite treatment increased mRNA production of p22phox (Figure 7). The -actin mRNA expression was designed to serve as an internal control; however, arsenite treatment apparently also decreased the -actin mRNA expression (Figure 7). Therefore, the normalizing of p22phox mRNA expression with -actin mRNA expression is invalid.

View larger version (33K): [in this window] [in a new window]   Figure 6. Effects of p22phox antisense oligonucleotide on the superoxide production and DNA strand breaks of arsenite (As)–treated cells. Cells without transfection or transfected with antisense or sense phox22 were treated with 10 µmol/L arsenite for 4 hours or were not treated. Superoxide production (A) was measured by chemiluminescence method, and DNA strand breaks (B) were analyzed by comet assay. N-Unt indicates without transfection and without arsenite treatment; A-Unt, transfected with phox22 antisense but without arsenite treatment; S-Unt, transfected with phox22 sense but without arsenite treatment; N-As, without transfection but with arsenite treatment; A-As, transfected with antisense phox22 and treated with arsenite; and S-As, transfected with sense phox22 and treated with arsenite. Results in panel A are from 1 of 3 experiments giving similar results. Results in panel B are from 3 independent experiments. **P<0.01, As-treated samples with vs samples without transfection.

View larger version (30K): [in this window] [in a new window]   Figure 7. Effects of treatment with arsenite on p22phox and -actin mRNA expression. Cells were treated with various concentrations of arsenite for 4 hours. Total RNA was then extracted, and p22phox and -actin mRNA expressions were analyzed by RT-PCR as described in Materials and Methods. Results are from 1 experiment.

Effects of Arsenite on Nonproliferating VSMCs
The above-described results were obtained from VSMCs that were cultured in 10% FCS plus growth factors. Therefore, it was unclear whether or not arsenite was affecting signaling systems that would be induced by these growth factors, or whether arsenite alone could cause these effects. We then repeated some of the experiments by using VSMCs that had been grown for 48 hours in medium containing only 0.1% FCS and without the addition of any other growth-promoting factors. The results indicate that the superoxide level of untreated cells was 0.44±0.03 nmol/minxmg protein^–1. This value is similar to that for VSMCs cultured in 10% FCS plus growth factors as reported by other investigators²³ and also as shown in Figure 5. Moreover, a doubling of the NADH oxidase activity was measured by a 4-hour treatment with 1 µmol/L arsenite (Figure 8A). A 4-hour treatment with arsenite at a concentration above 1 µmol/L also increased DNA strand breaks (Figure 8B). The induction of DNA strand break was even more apparent with the Fpg digestion (Figure 8B). Therefore, the increase of NADH oxidase activity by arsenite seems not to be due to the interaction of arsenite with the signals induced by growth factors.

View larger version (19K): [in this window] [in a new window]   Figure 8. Effects of treatment with arsenite on NADH oxidase activity and DNA integrity in nonproliferating VSMCs. VSMCs grown in complete medium were switched to medium containing only 0.1% FCS and without any other growth-promoting factors for 48 hours. Cells were then treated with arsenite for 4 hours. A, NADH oxidase activity was determined by using 100 µmol/L NADH as electron donor. B, Comet assay was done without () or with (•) Fpg digestion. Results are from 3 experiments. **P<0.01, samples with vs samples without arsenite.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

 
The oxidation of dichlorofluorescein is widely used to monitor the intracellular oxidative status, and arsenite has been shown to oxidize dichlorofluorescein.^{24 25} This result suggests that treatment with arsenite may increase intracellular peroxide levels. However, we have previously shown that the increase of dichlorofluorescein fluorescence by treatment with arsenite in Chinese hamster ovary cells is due to the induction of nitric oxide.¹⁹ In this investigation, superoxide was measured by the lucigenin-mediated chemiluminescence method. The elevation of superoxide production by treatment with arsenite was made evident by the observation that an appreciable increase of chemiluminescence was detected only when NADH or NADPH was added to the reaction mixture, and the chemiluminescence in extract from arsenite-treated cells was reduced by superoxide dismutase, Tiron, or diphenylene iodinium, but not by nitric oxide synthase inhibitors. This notion is further supported by the observation that arsenite-induced superoxide production was suppressed by the antisense but not by the sense oligonucleotide of p22phox. Therefore, the present experiments provide strong evidence that treatment with arsenite can increase intracellular superoxide levels and that this probably resulted from activation of NADH oxidase. Although the present results also show that arsenite increased the mRNA level of p22phox, it is still premature to conclude that this is the mechanism by which arsenite activates NADH oxidase. Further research is needed to elucidate how this is done. The present results show that treatment with arsenite increases DNA strand breaks, and this is due to oxidative DNA damage, as is evident by its sensitivity to various oxidant modulators and to Fpg, but not to nitric oxide synthase inhibitors. In contrast to the present finding, arsenite has been shown to induce DNA damage¹² and micronuclei¹⁹ through the generation of nitric oxide in Chinese hamster ovary cells. Therefore, it seems that different genotoxic mechanisms are involved with arsenite treatment in different types of cells.

The present results show that a 4-hour treatment with arsenite at a concentration above 1 µmol/L increases superoxide levels and oxidative DNA damage in VSMCs. This concentration is consistent with the report that the arsenic concentration in red blood cells of residents exposed to arsenic from drinking water reaches 1.2 µmol/L.¹⁴ Using a comet assay, we also examined the induction of DNA strand breaks by a 4-hour treatment with arsenite in human umbilical vein endothelial cells. The results indicate that apparent DNA strand breaks were detected only by treatment with arsenite at concentrations above 5 µmol/L (data not shown). Because data regarding the sensitivity of other types of cells in human blood vessels are not yet available, it is premature to conclude that VSMCs are the most sensitive target for arsenite. However, the demonstration that arsenite at very low concentrations can induce superoxide and oxidative DNA damage in VSMCs suggests that oxidative stress may be an important etiology in arsenic-induced vascular disorders. The DNA strand breaks detected in the present experiments may account for the chromosomal rearrangements in atherosclerotic plaques described by Casalone et al.²⁶ These results are consistent with the view that an increase in the mutation rate may be involved in the formation of atherosclerotic plaques.²⁷ In fact, arsenite has been shown to induce gene mutation through reactive oxygen species.²⁸ In addition to DNA damage, VSMC-derived reactive oxygen species may also promote proatherogenic processes by affecting VSMC proliferation²⁹ and chemotaxis^{30 31} through the activation of nuclear factor B,³² oxidative modification of LDL,^{33 34} and induction of the immediate early genes c-myc and c-fos.³⁵ Arsenite has also been shown to initiate gene transcription by altering signal-transduction molecules.^{36 37} However, much higher concentrations of arsenite were used in these studies. Therefore, the involvement of signal molecules in arsenite-induced human disorders remains to be determined.

	Acknowledgments

 
This work was supported by grants from the National Science Council and from Academia Sinica.

Received August 6, 1999; accepted November 30, 1999.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 
1. Chen CJ, Wang CJ. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res. 1990;50:5470–5474.[Abstract/Free Full Text]

2. Chen CJ, Chen CW, Wu MM, Kuo TL. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer. 1992;66:888–892.[Medline] [Order article via Infotrieve]

3. Falk H, Caldwell GG, Ishak KG, Thomas LB, Popper H. Arsenic-related hepatic angiosarcoma. Am J Ind Med. 1981;2:43–50.[Medline] [Order article via Infotrieve]

4. Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY. Atherogenicity and carcinogenicity of high-arsenic artesian well water: multiple risk factors and related malignant neoplasms of Blackfoot disease. Arteriosclerosis. 1988;8:452–460.[Abstract/Free Full Text]

5. Rahman M, Tondel M, Ahmad SA, Chowdhury IA, Faruquee MH, Axelson O. Hypertension and arsenic exposure in Bangladesh. Hypertension. 1999;33:74–78.[Abstract/Free Full Text]

6. Hansen ES. International Commission for Protection Against Environmental Mutagens and Carcinogens: ICPEMC Working Paper 7/1/2: shared risk factors for cancer and atherosclerosis: a review of the epidemiological evidence. Mutat Res. 1990;239:163–179.[Medline] [Order article via Infotrieve]

7. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A. 1973;70:1753–1756.[Abstract/Free Full Text]

8. Penn A, Garte SJ, Warren L, Nesta D, Mindich B. Transforming gene in human atherosclerotic plaque DNA. Proc Natl Acad Sci U S A. 1986;83:7951–7955.[Abstract/Free Full Text]

9. Nordenson I, Beckman L. Occupational and environmental risks in and around a smelter in northern Sweden, VII: reanalysis and follow-up of chromosomal aberrations in workers exposed to arsenic. Hereditas. 1982;96:175–181.[Medline] [Order article via Infotrieve]

10. Wen WN, Lieu TL, Chang HJ, Wuu SW, Yau ML, Jan KY. Baseline and sodium arsenite-induced sister chromatid exchanges in cultured lymphocytes from patients with Blackfoot disease and healthy persons. Hum Genet. 1981;59:201–203.[Medline] [Order article via Infotrieve]

11. Wiencke JK, Yager JW, Varkonyi A, Hultner M, Lutze LH. Study of arsenic mutagenesis using the plasmid shuttle vector pZ189 propagated in DNA repair proficient human cells. Mutat Res. 1997;386:335–344.[Medline] [Order article via Infotrieve]

12. Lynn S, Shiung JN, Gurr JR, Jan KY. Arsenite stimulates poly(ADP-ribosylation) by generation of nitric oxide. Free Radic Biol Med. 1998;24:442–449.[Medline] [Order article via Infotrieve]

13. Yamanaka K, Hayashi H, Kato K, Hasegawa A, Okada S. Involvement of preferential formation of apurinic/apyrimidinic sites in dimethylarsenic-induced DNA strand breaks and DNA-protein crosslinks in cultured alveolar epithelial cells. Biochem Biophys Res Commun. 1995;207:244–249.[Medline] [Order article via Infotrieve]

14. Heydorn K. Environmental variation of arsenic levels in human blood determines by neutron activation analysis. Clin Chim Acta. 1970;28:349–357.[Medline] [Order article via Infotrieve]

15. Liu F, Jan KY. DNA damage in arsenite- and cadmium-treated bovine aortic endothelial cells. Free Radic Biol Med. 2000;28:55–63.[Medline] [Order article via Infotrieve]

16. Van Gelder BF, Slater EC. The extinction coefficient of cytochrome C. Biochim Biophys Acta. 1962;58:593–595.[Medline] [Order article via Infotrieve]

17. Fukui T, Lassegue B, Kai H, Alexander RW, Griendling KK. Cytochrome b-558 alpha-subunit cloning and expression in rat aortic smooth muscle cells. Biochim Biophys Acta. 1995;1231:215–219.[Medline] [Order article via Infotrieve]

18. Greiber S, Munzel T, Kastner S, Muller B, Schollmeyer P, Pavenstadt H. NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate. Kidney Intl. 1998;53:654–663.[Medline] [Order article via Infotrieve]

19. Gurr JR, Liu F, Lynn S, Jan KY. Calcium-dependent nitric oxide production is involved in arsenite-induced micronuclei. Mutat Res. 1998;416:137–148.[Medline] [Order article via Infotrieve]

20. Wang TS, Shu YF, Liu YC, Jan KY, Huang H. Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. Toxicology. 1997;121:229–237.[Medline] [Order article via Infotrieve]

21. Tchou J, Kasai H, Shibutani S, Chung MH, Laval J, Grollman AP, Nishimura S. 8-Oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc Natl Acad Sci U S A. 1991;88:4690–4694.[Abstract/Free Full Text]

22. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141–1148.[Abstract/Free Full Text]

23. Bhunia AK, Han H, Snowden A, Chatterjee S. Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J Biol Chem. 1997;272:15642–15649.[Abstract/Free Full Text]

24. Lee TC, Ho IC. Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblasts. Arch Toxicol. 1995;69:498–504.[Medline] [Order article via Infotrieve]

25. Wang TS, Kuo CF, Jan KY, Huang H. Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J Cell Physiol. 1996;169:256–268.[Medline] [Order article via Infotrieve]

26. Casalone R, Granata P, Minelli E, Portentoso P, Giudici A, Righi R, Castelli P, Socrate A, Frigerio B. Cytogenetic analysis reveals clonal proliferation of smooth muscle cells in atherosclerotic plaques. Hum Genet. 1991;87:139–143.[Medline] [Order article via Infotrieve]

27. Hatzistamou J, Kiaris H, Ergazaki M, Spandidos DA. Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques. Biochem Biophys Res Commun. 1996;225:186–190.[Medline] [Order article via Infotrieve]

28. Hei TK, Liu SX, Waldren C. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc Natl Acad Sci U S A. 1998;95:8103–8107.[Abstract/Free Full Text]

29. Patterson C, Ruef J, Madamanchi NR, Barry-Lane P, Hu Z, Horaist C, Ballinger CA, Brasier AR, Bode C, Runge MS. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin: evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J Biol Chem. 1999;274:19814–19822.[Abstract/Free Full Text]

30. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science. 1995;270:296–299.[Abstract/Free Full Text]

31. Nishio E, Watanabe Y. The involvement of reactive oxygen species and arachidonic acid in alpha 1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br J Pharmacol. 1997;121:665–670.[Medline] [Order article via Infotrieve]

32. Marumo T, Schini-Kerth VB, Fisslthaler B, Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation. 1997;96:2361–2367.[Abstract/Free Full Text]

33. Heinecke JW, Baker L, Rosen H, Chait A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest. 1986;77:757–761.

34. Steinberg D. Lewis A. Conner Memorial Lecture: oxidative modification of LDL and atherogenesis. Circulation. 1997;95:1062–1071.[Free Full Text]

35. Rao GN, Lassegue B, Griendling KK, Alexander RW. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidonic acid. Oncogene. 1993;8:2759–2764.[Medline] [Order article via Infotrieve]

36. Elbirt KK, Whitmarsh AJ, Davis RJ, Bonkovsky HL. Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells: role of mitogen-activated protein kinases. J Biol Chem. 1998;273:8922–8931. (Correction. J Biol Chem. 1998;273:179).[Abstract/Free Full Text]

37. Masuya Y, Hioki K, Tokunaga R, Taketani S. Involvement of the tyrosine phosphorylation pathway in induction of human heme oxygenase-1 by hemin, sodium arsenite, and cadmium chloride. J Biochem (Tokyo). 1998;124:628–633.[Abstract/Free Full Text]

This article has been cited by other articles:

				A. C. Straub, L. R. Klei, D. B. Stolz, and A. Barchowsky Arsenic Requires Sphingosine-1-Phosphate Type 1 Receptors to Induce Angiogenic Genes and Endothelial Cell Remodeling Am. J. Pathol., May 1, 2009; 174(5): 1949 - 1958. [Abstract] [Full Text] [PDF]

				J. C. States, S. Srivastava, Y. Chen, and A. Barchowsky Arsenic and Cardiovascular Disease Toxicol. Sci., February 1, 2009; 107(2): 312 - 323. [Abstract] [Full Text] [PDF]

				A. M. Hays, R. C. Lantz, L. S. Rodgers, J. J. Sollome, R. R. Vaillancourt, A. S. Andrew, J. W. Hamilton, and T. D. Camenisch Arsenic-Induced Decreases in the Vascular Matrix Toxicol Pathol, October 1, 2008; 36(6): 805 - 817. [Abstract] [Full Text] [PDF]

				A. Lemarie, E. Bourdonnay, C. Morzadec, O. Fardel, and L. Vernhet Inorganic Arsenic Activates Reduced NADPH Oxidase in Human Primary Macrophages through a Rho Kinase/p38 Kinase Pathway J. Immunol., May 1, 2008; 180(9): 6010 - 6017. [Abstract] [Full Text] [PDF]

				O.-N. Bae, K.-M. Lim, J.-Y. Han, B.-I. Jung, J.-Y. Lee, J.-Y. Noh, S.-M. Chung, M.-Y. Lee, J.-Y. Lee, and J.-H. Chung U-shaped Dose Response in Vasomotor Tone: A Mixed Result of Heterogenic Response of Multiple Cells to Xenobiotics Toxicol. Sci., May 1, 2008; 103(1): 181 - 190. [Abstract] [Full Text] [PDF]

				L. R. Klei and A. Barchowsky Positive Signaling Interactions between Arsenic and Ethanol for Angiogenic Gene Induction in Human Microvascular Endothelial Cells Toxicol. Sci., April 1, 2008; 102(2): 319 - 327. [Abstract] [Full Text] [PDF]

				Z. Peng, L. Peng, Y. Fan, E. Zandi, H. G. Shertzer, and Y. Xia A Critical Role for I{kappa}B Kinase beta in Metallothionein-1 Expression and Protection against Arsenic Toxicity J. Biol. Chem., July 20, 2007; 282(29): 21487 - 21496. [Abstract] [Full Text] [PDF]

				S.-C. Chen, M.-H. Tsai, H.-J. Wang, H.-S. Yu, and L. W. Chang Involvement of Substance P and Neurogenic Inflammation in Arsenic-Induced Early Vascular Dysfunction Toxicol. Sci., January 1, 2007; 95(1): 82 - 88. [Abstract] [Full Text] [PDF]

				C. Santos, M. Gaspar, A. Caeiro, C. Branco-Price, A. Teixeira, and R. B. Ferreira Exposure of Lemna minor to Arsenite: Expression Levels of the Components and Intermediates of the Ubiquitin/Proteasome Pathway Plant Cell Physiol., September 1, 2006; 47(9): 1262 - 1273. [Abstract] [Full Text] [PDF]

				J. L. C. Bilszta, G. J. Dusting, and F. Jiang Arsenite Increases Vasoconstrictor Reactivity in Rat Blood Vessels: Role of Endothelial Nitric Oxide Function International Journal of Toxicology, July 1, 2006; 25(4): 303 - 310. [Abstract] [Full Text] [PDF]

				K.-Y. Jan, T.-C. Wang, B. Ramanathan, and J.-R. Gurr Dithiol Compounds at Low Concentrations Increase Arsenite Toxicity Toxicol. Sci., April 1, 2006; 90(2): 432 - 439. [Abstract] [Full Text] [PDF]

				J.-I Chao, S.-H. Hsu, and T.-C. Tsou Depletion of Securin Increases Arsenite-Induced Chromosome Instability and Apoptosis via a p53-Independent Pathway Toxicol. Sci., March 1, 2006; 90(1): 73 - 86. [Abstract] [Full Text] [PDF]

				J.-M. Chiou, S.-L. Wang, C.-J. Chen, C.-R. Deng, W. Lin, and T.-Y. Tai Arsenic ingestion and increased microvascular disease risk: observations from the south-western arseniasis-endemic area in Taiwan Int. J. Epidemiol., August 1, 2005; 34(4): 936 - 943. [Abstract] [Full Text] [PDF]

				P.-C. Lee, I-C. Ho, and T.-C. Lee Oxidative Stress Mediates Sodium Arsenite-Induced Expression of Heme Oxygenase-1, Monocyte Chemoattractant Protein-1, and Interleukin-6 in Vascular Smooth Muscle Cells Toxicol. Sci., May 1, 2005; 85(1): 541 - 550. [Abstract] [Full Text] [PDF]

				Y. Qian, K. J. Liu, Y. Chen, D. C. Flynn, V. Castranova, and X. Shi Cdc42 Regulates Arsenic-induced NADPH Oxidase Activation and Cell Migration through Actin Filament Reorganization J. Biol. Chem., February 4, 2005; 280(5): 3875 - 3884. [Abstract] [Full Text] [PDF]

				W.-C. Chou, C. Jie, A. A. Kenedy, R. J. Jones, M. A. Trush, and C. V. Dang Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells PNAS, March 30, 2004; 101(13): 4578 - 4583. [Abstract] [Full Text] [PDF]

				T. Ago, T. Kitazono, H. Ooboshi, T. Iyama, Y. H. Han, J. Takada, M. Wakisaka, S. Ibayashi, H. Utsumi, and M. Iida Nox4 as the Major Catalytic Component of an Endothelial NAD(P)H Oxidase Circulation, January 20, 2004; 109(2): 227 - 233. [Abstract] [Full Text] [PDF]

				L.-H. Yih and T.-C. Lee Induction of C-Anaphase and Diplochromosome through Dysregulation of Spindle Assembly Checkpoint by Sodium Arsenite in Human Fibroblasts Cancer Res., October 15, 2003; 63(20): 6680 - 6688. [Abstract] [Full Text] [PDF]

				B. Lassegue and R. E. Clempus Vascular NAD(P)H oxidases: specific features, expression, and regulation Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R277 - R297. [Abstract] [Full Text] [PDF]

				T. Schwerdtle, I. Walter, I. Mackiw, and A. Hartwig Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA Carcinogenesis, May 1, 2003; 24(5): 967 - 974. [Abstract] [Full Text] [PDF]

				C.-H. Tseng An Overview on Peripheral Vascular Disease in Blackfoot Disease-Hyperendemic Villages in Taiwan Angiology, September 1, 2002; 53(5): 529 - 537. [Abstract] [PDF]

				L Van Heerebeek, C Meischl, W Stooker, C J L M Meijer, H W M Niessen, and D Roos NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J. Clin. Pathol., August 1, 2002; 55(8): 561 - 568. [Abstract] [Full Text] [PDF]

				L.-H. Yih, K. Peck, and T.-C. Lee Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment Carcinogenesis, May 1, 2002; 23(5): 867 - 876. [Abstract] [Full Text] [PDF]

				M. C. A. Duyndam, T. M. Hulscher, D. Fontijn, H. M. Pinedo, and E. Boven Induction of Vascular Endothelial Growth Factor Expression and Hypoxia-inducible Factor 1alpha Protein by the Oxidative Stressor Arsenite J. Biol. Chem., December 14, 2001; 276(51): 48066 - 48076. [Abstract] [Full Text] [PDF]

				J. B. Wijeweera, A. J. Gandolfi, A. Parrish, and R. C. Lantz Sodium Arsenite Enhances AP-1 and NF{{kappa}} B DNA Binding and Induces Stress Protein Expression in Precision-Cut Rat Lung Slices Toxicol. Sci., June 1, 2001; 61(2): 283 - 294. [Abstract] [Full Text] [PDF]

				D.T. Bau, J.R. Gurr, and K.Y. Jan Nitric oxide is involved in arsenite inhibition of pyrimidine dimer excision Carcinogenesis, May 1, 2001; 22(5): 709 - 716. [Abstract] [Full Text] [PDF]

				K. R. Smith, L. R. Klei, and A. Barchowsky Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells Am J Physiol Lung Cell Mol Physiol, March 1, 2001; 280(3): L442 - L449. [Abstract] [Full Text] [PDF]

				C.-C. Hsieh, M.-H. Yen, C.-H. Yen, and Y.-T. Lau Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells Cardiovasc Res, January 1, 2001; 49(1): 135 - 145. [Abstract] [Full Text] [PDF]

				R. Uslu, U. A. Sanli, C. Sezgin, B. Karabulut, E. Terzioglu, S. B. Omay, and E. Goker Arsenic Trioxide-mediated Cytotoxicity and Apoptosis in Prostate and Ovarian Carcinoma Cell Lines Clin. Cancer Res., December 1, 2000; 6(12): 4957 - 4964. [Abstract] [Full Text]

				W.-G. Li, F. J. Miller Jr., H. J. Zhang, D. R. Spitz, L. W. Oberley, and N. L. Weintraub H2O2-induced O-.2 Production by a Non-phagocytic NAD(P)H Oxidase Causes Oxidant Injury J. Biol. Chem., July 27, 2001; 276(31): 29251 - 29256. [Abstract] [Full Text] [PDF]

				S. S. Brar, T. P. Kennedy, A. B. Sturrock, T. P. Huecksteadt, M. T. Quinn, A. R. Whorton, and J. R. Hoidal An NAD(P)H oxidase regulates growth and transcription in melanoma cells Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1212 - C1224. [Abstract] [Full Text] [PDF]

				S. S. Brar, T. P. Kennedy, A. B. Sturrock, T. P. Huecksteadt, M. T. Quinn, T. M. Murphy, P. Chitano, and J. R. Hoidal NADPH oxidase promotes NF-kappa B activation and proliferation in human airway smooth muscle Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L782 - L795. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Methods Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lynn, S. Articles by Jan, K.-Y. Search for Related Content PubMed PubMed Citation Articles by Lynn, S. Articles by Jan, K.-Y. Related Collections Smooth muscle proliferation and differentiation Peripheral vascular disease Oxidant stress Mechanism of atherosclerosis/growth factors